Products for Research Use Only
RegisterLogin

Ontorpacept

CAT: 0804-HY-P99777-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99777-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ontorpacept (TTI-621) is a soluble fusion protein that consists of the human SIRPα N-terminal (1-118) linked to the Fc region of human IgG1. The N-terminal (1-118) -fragment of ontorpacept is a binding domain for CD47 which is an inhibitor of phagocytosis by macrophages. Ontorpacept is a CD47-blocking checkpoint inhibitor with antitumor activity[1].
CAS Number
2131089-46-6
Product Name Alternative
TTI-621
UNSPSC
12352203
Target
CD47
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ontorpacept.html
Purity
99.57
Solubility
10 mM in DMSO
Smiles
[Ontorpacept]
Molecular Weight
(76.43 kDa)
References & Citations
[1]Petrova PS, et al. TTI-621 (SIRPαFc) : A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding. Clin Cancer Res. 2017 Feb 15;23 (4) :1068-1079.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T81605-01Ontorpacept
GTR18333635-01Ontorpacept Antibody
HC359336-01Research Grade Ontorpacept
GTR18696801-01Ontorpacept Monoclonal Antibody
E55B1163Ontorpacept (Reference antibody)
ICH5735-5mgOntorpacept Biosimilar - Research Grade
PX-TA2019-01Ontorpacept Biosimilar - Anti-CD47 fusion protein - Research Grade
A136008Ontorpacept Biosimilar (, Fusion - SIRPA (signal regulatory protein alpha, SHPS1, SIRP, SIRPalpha) - IGHG1 (Fc (Fragment constant) )

Popular Products